UNSPSC 51262507: Guanoxan sulfate

This classification denotes a guanidine and antihypertensive agent 2C10H13N3O2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6IT80R85G, chemically known as (1,4-benzodioxan-2-yl-methyl)guanidine sulfate (2:1), but more generally known as guanoxan sulfate, which bears US NIH Compound Identifier 21942. European Medicines Agency schedules Guanoxan sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02432MIG.

Most nations, for tariff and trade purposes, schedule guanoxan sulfate under HS 29329985 and SITC 51569. As of Q4 2014, GUANOXAN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC2C(C1)OCC(O2)CNC(=N)N.C1CCC2C(C1)OCC(O2)CNC(=N)N.OS(=O)(=O)O.

UNSPSC 51262507 Guanoxan sulfate is a Commodity code that covers pharmaceutical compounds, though recent state and local procurement activity under this code shows minimal relevance to the nominal scope. Guanoxan sulfate is a vasodilator pharmaceutical, yet the single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, which are opioid-overdose reversal agents and harm-reduction equipment unrelated to guanoxan sulfate's therapeutic class. The mismatch suggests either a tagging error in the source database or that the code is used opportunistically to describe a broader pharmaceutical-procurement category. Issuing bodies posting under this code include county health and community services departments.

Seminole County, Florida posted the only recent opportunity identifiable under this code. The IFB, posted June 30, 2026 with a response deadline of July 26, 2023, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, and vendors must provide unit pricing, maintain workers' compensation and liability insurance, pass E-Verify employment eligibility verification, and comply with federal requirements including the Clean Air Act. Bidders bear all shipping and delivery costs. The procurement shows minimal recent activity under this code, suggesting either low demand for guanoxan sulfate specifically or widespread miscoding of pharmaceutical procurements in state and local systems.